TLSA Tiziana Life Sciences Ltd

Nasdaq tizianalifesciences.com


$ 2.16 $ 0.01 (0.47 %)    

Tuesday, 14-Oct-2025 15:59:50 EDT
QQQ $ 598.13 $ -4.01 (-0.67 %)
DIA $ 462.92 $ 2.03 (0.44 %)
SPY $ 662.18 $ -0.81 (-0.12 %)
TLT $ 90.67 $ 0.29 (0.32 %)
GLD $ 381.35 $ 2.70 (0.71 %)
$ 2.14
$ 2.06
$ 2.10 x 66
$ 2.13 x 4
$ 2.01 - $ 2.19
$ 0.63 - $ 2.60
187,214
na
nm
$ -0.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tiziana-announces-it-will-advance-its-second-asset-a-fully-human-anti-il-6-receptor-monoclonal-antibody-tzls-501-tiziana-will-pursue-non-dilutive-funding-strategies-for-the-development-of-tzls-501-while-continuing-to-advance-intranasal-foralumab-as-its-lead-program

Tiziana Life Sciences, Ltd. (NASDAQ: TLSA) ("Tiziana" or the "Company"), today announces it will advance its se...

 tiziana-life-sciences-chairman-gabriele-cerrone-buys-25k-shares-at-160-now-holds-3628-of-issued-capital

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 lucid-is-now-shipping-adapters-that-let-customers-access-elon-musk-led-teslas-supercharger-network

Lucid ships adapters for Air Sedan allowing owners to access over 23,500 Tesla Supercharging stations across the U.S.

 tiziana-life-sciences-announced-immunologic-findings-from-the-treatment-of-a-moderate-alzheimers-disease-patient-with-intranasal-foralumab

Transcriptional analysis of white blood cells before and after foralumab therapy revealed profound immune modulatory effects. S...

 tiziana-life-sciences-executive-chairman-and-founder-gabriele-cerrone-increases-stake-to-3702-with-15000-share-purchase-total-holding-reaches-4325m

Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing break...

 tiziana-life-sciences-announces-results-of-pet-scan-showing-marked-reduction-in-microglia-activation-associated-with-neuroinflammation-in-ad-patient-treated-with-intranasal-foralumab

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

 tiziana-life-sciences-announces-comprehensive-positive-results-from-study-of-nasal-foralumab-in-patients-with-multiple-sclerosis

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION